A 26 week randomised, double blind, placebo controlled exploratory study of sulfasalazine in juvenile onset spondyloarthropathies

[...]we conducted a phase III, exploratory, 26 week prospective, randomised, double blind, placebo controlled trial of SSZ in active juvenile SpA.

Saved in:
Bibliographic Details
Published in:Annals of the rheumatic diseases 2002-10, Vol.61 (10), p.941-942
Main Authors: Burgos-Vargas, R, Vázquez-Mellado, J, Pacheco-Tena, C, Hernández-Garduño, A, Goycochea-Robles, M V
Format: Article
Language:English
Subjects:
Adolescent
Anti-Inflammatory Agents, Non-Steroidal - therapeutic use
Antirheumatic Agents - therapeutic use
Arthritis, Juvenile - drug therapy
Biological and medical sciences
Bones, joints and connective tissue. Antiinflammatory agents
Double-Blind Method
Drug therapy
Evaluation
Female
Humans
juvenile arthritis
Letter
Male
Medical sciences
Pain
Patients
Pharmacology. Drug treatments
Prospective Studies
Spondylitis, Ankylosing - drug therapy
Spondyloarthropathies
spondyloarthropathy
Sulfasalazine
Sulfasalazine - therapeutic use
Variables
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:[...]we conducted a phase III, exploratory, 26 week prospective, randomised, double blind, placebo controlled trial of SSZ in active juvenile SpA.
ISSN:0003-4967
1468-2060
DOI:10.1136/ard.61.10.941